๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

โœ Scribed by Paccagnella, Adriano; Favaretto, A.; Oniga, F.; Barbieri, F.; Ceresoli, G.; Torri, W.; Villa, E.; Verusio, C.; Cetto, G.L.; Santo, A.; De Pangher, V.; Artioli, F.; Cacciani, G.C.; Parodi, G.; Soresi, F.; Ghi, M.G.; Morabito, A.; Biason, R.; Giusto, M.; Mosconi, P.; Chiarion Sileni, V.

Book ID
118571197
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
117 KB
Volume
43
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase III trial of gemcitabine and carbo
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma
โœ Sarah Danson; Mark R. Middleton; Kenneth J. O'Byrne; Mark Clemons; Malcolm Ranso ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 325 KB

## Abstract ## BACKGROUND The authors compared gemcitabine and carboplatin (GC) with mitomycin, ifosfamide, and cisplatin (MIC) or mitomycin, vinblastine, and cisplatin (MVP) in patients with advanced nonsmall cell lung carcinoma (NSCLC). The primary objective was survival. Secondary objectives we